Gender differences in the evolution of illness understanding among patients with advanced cancerAugust 21, 2013Patient & Survivor Care
Chlorpromazine bioavailability from a topical gel formulation in volunteersAugust 21, 2013Patient & Survivor Care
Complementary and alternative medicine (CAM) use in advanced cancer: a systematic reviewAugust 21, 2013Patient & Survivor Care
Best practices for pediatric palliative cancer care: a primer for clinical providersAugust 21, 2013Patient & Survivor Care
Continuous imatinib therapy in patients with gastrointestinal stromal tumorsAugust 13, 2013Gastroenterology
Nab-paclitaxel in first-line treatment of advanced non–small-cell lung cancerAugust 13, 2013Lung Cancer
Oncologist compensation deserves evidence-based scrutiny and analysisAugust 12, 2013Patient & Survivor CareBusiness of Medicine
Other therapy options may relegate omacetaxine to last-line choice for chronic or accelerated phase CMLJuly 6, 2013
Enzalutamide in castrate-resistant prostate cancer after chemotherapyJuly 3, 2013Genitourinary Cancer
Practical considerations in the delivery of genetic counseling and testing services for inherited cancer predispositionJuly 3, 2013Patient & Survivor Care
Ensuring optimal adherence to BCR-ABL1 tyrosine kinase inhibitor therapy for chronic myeloid leukemiaJuly 2, 2013Leukemia, Myelodysplasia, Transplantation
